Loading...
Biosimilar Setbacks Will Curb Returns But Slight Hope Endures
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
59.9%7D
-11.2%1Y
59.9%7D
-11.2%You can edit this narrative until Aug 12 11:02 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 12 11:02 PM. Then, changes will post as Updates.